Point and Figure Charting Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Point and Figure Charting

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mr. BSL who wrote (14031)	2/16/1999 10:14:00 AM
From: Logain Ablar	Read Replies (1) of 34811

Dick: OTOT Henry is a zealot on Ligand (LGND) and I would not call / put him in the category of a spammer. He is focused on Ligand and its hope for the future. He may hype Ligand but I beleive that is due to his focusing too much on its technology versus its fundamentals and technicals. If you click on his name and go back through his postings you'll be able to see this. Also, as he hypes Ligand (which obtained 2 FDA approvals recently) one must access the stock (i.e. even with approvals the company won't make money, low revenue, by drug standards) and its risk. Henry only looks at the glass as being full with LGND vs. half empty. Now the company may start to make money if some of its more promising drugs make it through PII and PIII trails. JMO Tim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next